SNDX
Syndax Pharmaceuticals Inc
17.40$
-2.6%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | -33.3% | -100.0% | – | -50.9% | -398.2% | – | +33.3% | +25.0% | – | |
| – | +0.1% | +6.9% | +11.2% | +20.6% | +3.0% | -15.6% | +32.8% | -12.4% | -6.9% | +7.1% | +16.3% | – | |
| – | +1,534.8% | -163.3% | – | – | +115.2% | -164.1% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -57.3% | -100.0% | – | – | |
| – | -140.6% | +510.2% | – | +40.6% | -409.7% | – | -55.5% | +72.9% | +12.6% | -52.9% | -144.1% | – | |
| – | +13,864.5% | -99.2% | -68.8% | +358.3% | +11,114.5% | -99.7% | -40.8% | +1,039.4% | -5.8% | +33.8% | +3,092.3% | – | |
| – | – | -190.0% | – | – | -23.7% | -100.4% | – | – | +120.3% | -122.4% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.